SELAGINE Inc. is a spin-out company from the University of Illinois at Chicago (UIC) that is commercializing technology which was developed within the UIC College of Medicine, Department of Ophthalmology. SELAGINE is focused on developing novel therapeutics to help patients suffering from a variety of debilitating ocular diseases, and to improve the quality of life in conditions where effective therapies do not exist.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.